INOGEN, INC. (NASDAQ:INGN) Files An 8-K Results of Operations and Financial Condition

Item 2.02.

On May 9, 2017, Inogen, Inc. issued a press release reporting its
financial results for the first quarter ended March 31, 2017. A
copy of the press release is furnished herewith as Exhibit 99.1
to this Current Report on Form 8-K.

The information furnished in this Current Report under Item 2.02
and the exhibit attached hereto shall not be deemed filed for
purposes of Section 18 of the Securities Exchange Act of 1934, as
amended (the Exchange Act), or incorporated by reference in any
filing under the Securities Act of 1933, as amended, or the
Exchange Act, except as shall be expressly set forth by specific
reference in such a filing.

(d)Exhibits

About INOGEN, INC. (NASDAQ:INGN)

Inogen, Inc. is a medical technology company. The Company is engaged in developing, manufacturing and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company’s Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device weighing approximately 4.8 or seven pounds. Its Inogen One G2 and Inogen One G3 have approximately five and 4.5 hours of battery life, respectively, with a single battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. The Inogen At Home stationary oxygen concentrator allows it to access the non-ambulatory patient market and serves as a backup to its Inogen One system for ambulatory patients. The Company sells its products to home medical equipment providers in the United States and in foreign countries.

INOGEN, INC. (NASDAQ:INGN) Recent Trading Information

INOGEN, INC. (NASDAQ:INGN) closed its last trading session down -0.44 at 83.77 with 205,699 shares trading hands.